Ultragenyx Pharmaceutical Inc. buy SVB Leerink LLC
Start price
30.12.25
/
50%
€17.00
Target price
30.12.26
€59.44
Performance (%)
6.47%
Price
31.03.26
€16.90
Summary
This prediction is currently active. With a performance of 6.47%, the BUY prediction by SVB_Leerink_LLC for Ultragenyx Pharmaceutical Inc. is trending in the right direction. This prediction currently runs until 30.12.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.170% | -1.170% |
| iShares Core DAX® | 0,75 % | -8,50 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % |
| iShares S&P 500 | -0,59 % | -2,87 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Leerink Partners from $80.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat